Power Law company profile

Orexo

Biotech & Life Sciences · Uppsala kommun, Sweden · Founded 1995 · IPO 2005 Thoroughbred

Pharmaceutical company developing improved treatments using proprietary drug delivery technology

Valuation

$34M

Market cap · May/2026

Revenue

$3.1M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

5 investors on Orexo's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 5 investors entered at this stage

Apex Venture Partners

Sofinnova Investments

HealthCap

Crédit Lyonnais Private Equity

Auriga Partners

Global footprint

Where Orexo has talent and traffic

Workforce by country

3 countries with
team presence

🇸🇪 Sweden77.8%

🇺🇸 United States20.6%

🇩🇰 Denmark1.7%

3 countries shown

Web traffic by country

3.8K monthly visits
across markets

🇺🇸 United States89.5%

🇸🇪 Sweden5.3%

🇳🇱 Netherlands5.3%

Top 3 markets shown

Market sentiment

What the market is saying about Orexo

An AI-synthesized read of the highest-engagement posts about Orexo on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Orexo on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles